Lipoprotein(a) as a risk factor for ischemic heart disease: Metaanalysis of prospective studies

Clinical Chemistry

Volumn 44, Issue 11, 1998, Pages 2301-2306

  Craig, Wendy Y ^a   Neveux, Louis M ^a   Palomaki, Glenn E ^a   Cleveland, Meghan M ^a   Haddow, James E ^a  

^a FOUNDATION FOR BLOOD RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPROTEIN A;

ARTICLE; CORONARY RISK; FAMILY HISTORY; HUMAN; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; META ANALYSIS; RISK ASSESSMENT; RISK FACTOR;

EID: 0031729386     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/44.11.2301     Document Type: Article

References (39)

1. Marcovina SM, Morrisett JD. Structure and metabolism of lipoprotein(a). Curr Opin Lipidol 1995;6:136-45.
2. McLean JW, Tomlinson JE, Kuang W-J, Eaton DL, Chen EY, Fless GM, et al. CDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 1987;300:132-7.
3. Liu AC, Lawn RM. Vascular interactions of lipoprotein(a). Curr Opin Lipidol 1994;5:269-73.
4. Kostner GM, Avogaro P, Cazzolato G, Marth E, Bittolo-Bon G, Qunici GB. Lipoprotein Lp(a) and the risk for myocardial infarction. Atherosclerosis 1981;38:51-61.
5. Rhoads GG, Dahlen G, Berg K, Morton NE, Dannenberg AL. Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA 1986; 256:2540-4.
6. Orth-Gomér K, Mittleman MA, Schenck-Gustafsson K, Wamala SP, Eriksson M, Belkic K, et al. Lipoprotein(a) as a determinant of coronary heart disease in young women. Circulation 1997;95: 329-34.
7. Cambillau M, Amar ASJ, Giral P, Atger V, Segond P, Levenson J, et al., and the PVCMETRA group. Serum Lp(a) as a discriminant marker of early atherosclerotic plaque at three extracoronary sites in hyper-cholesterolemic men. Arterioscler Thromb 1992;12:1346-52.
8. Farrer M, Game FL, Albers CJ, Neil HAW, Winocour PH, Laker MF, et al. Coronary artery disease is associated with increased lipoprotein(a) concentrations independent of the size of circulating apolipoprotein(a) isoforms. Arterioscler Thromb 1994;14:1272-83.
9. Dahlen GH, Guyton JR, Attar M, Farmer JA, Kautz JA, Gotto AM Jr. Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation 1986;74:758-65.
10. Budde T, Fechtrup C, Bösenberg E, Vielhauer C, Enbergs A, Schulte H, et al. Plasma Lp(a) levels correlate with number, severity, and length extension of coronary lesions in male patients undergoing coronary arteriography for clinically suspected coronary atherosclerosis. Arterioscler Thromb 1994;14:1730-6.
11. Barnathan ES. Has lipoprotein "little" (a) shrunk? JAMA 1993; 270:2195-9.
12. Gurewich V, Mittleman M. Lipoprotein(a) in coronary heart dis ease. Is it a risk factor after all? JAMA 1994;271:1025-6.
13. Kronenberg F, Trenkwalder E, Dieplinger H, Utermann G. Lipoprotein(a) in stored plasma samples and the ravages of time. Why epidemiologic studies might fail. Arterioscler Thromb Vase Biol 1996;16:1568-72.
14. Ridker PM. An epidemiologic reassessment of lipoprotein(a) and atherothrombotic risk. Trends Cardiovasc Med 1995;5:225-9.
15. Cressman MD, Heyka RJ, Paganini EP, O'Neil J, Skibinski CI, Hoff HF. Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients. Circulation 1992;86:475-82.
16. Haffner SM, Moss SE, Klein BEK, Klein R. Lack of association between lipoprotein(a) concentrations and coronary heart disease mortality in diabetes: the Wisconsin epidemiologic study of diabetic retinopathy. Metabolism 1992;41:194-7.
17. Bostom AG, Gagnon DR, Cupples LA, Wilson PWF, Jenner JL, Ordovas JM, et al. A prospective investigation of elevated lipoprotein(a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study. Circulation 1994;90: 1688-95.
18. Bostom AG, Cupples LA, Jenner JL, Ordovas JM, Seman LJ, Wilson PWF, et al. Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study. JAMA 1996;276:544-8.
19. Nguyen TT, Ellefson RD, Hodge DO, Bailey KR, Kottke TE, AbuLebdeh HS. Predictive value of electrophoretically detected Iipoprotein(a) for coronary heart disease in a community-based cohort of 9936 men and women. Circulation 1997;96:1390-7.
20. Marcovina SM, Albers JJ, Gabel B, Koschinsky ML, Gaur VP. Effect of the number of apolipoprotein(a) kringle 4 domains on immunochemical measurements of lipoprotein(a). Clin Chem 1995;41: 246-55.
21. Sigurdsson G, Baldursdottir A, Sigvaldason H, Agnarsson U, Thorgeirsson G, Sigfusson N. Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men. Am J Cardiol 1992;69:1251-4.
22. Alfthan G, Pekkanen J, Jauhiainen M. Pitkäniemi J, Karvonen M, Tuomilehto J, et al. Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis 1994;106:9-19.
23. Cremer P, Nagel D, Labrot B, Mann H, Muche R, Elster H, et al. Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS). Eur J Clin Investig 1994;24:444-53.
24. Jauhiainen M, Koskinen P, Ehnholm C, Frick MH, Mänttäri M, Manninen V, et al. Lipoprotein(a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants. Atherosclerosis 1991;89:59-67.
25. Ridker PM, Hennekens CH, Stampfer MJ. A prospective study of lipoprotein(a) and the risk of myocardial infarction. JAMA 1993; 270:2195-9.
26. Schaefer EJ, Lamon-Fava S, Jenner JL, McNamara JR, Ordovas JM, Davis CE, et al. Lipoprotein(a) levels and risk of coronary heart disease in men. The Lipid Research Clinics Coronary Primary Prevention Trial. JAMA 1994;271:999-1003.
27. Wild SH, Fortmann SP, Marcovina SM. A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford Five-City Project participants. Arterioscler Thromb Vase Biol 1997;17:239-45.
28. Coleman MP, Key TJA, Wang DY, Hermon C, Fentiman IS, Allen DS, et al. A prospective study of obesity, lipids, apolipoproteins and ischaemic heart disease in women. Atherosclerosis 1992; 92:177-85.
29. Klausen IC, Sjøl A, Hansen PS, Gerdes LU, Møller L, Lemming L, et al. Apolipoprotein(a) isoforms and coronary heart disease in men. A nested case-control study. Atherosclerosis 1997;132:77-84.
30. Rosengren A, Wilhelmsen L, Eriksson E, Risberg B, Wedel H. Lipoprotein(a), coronary heart disease: a prospective case-control study in a general population sample of middle aged men. Br Med J 1990;301:1248-51.
31. Wald NJ, Law M, Watt HC, Wu T, Bailey A, Johnson AM, et al. Apolipoproteins and ischaemic heart disease: implications for screening. Lancet 1994;343:75-9.
32. Assmann G, Schulte H, von Eckardstein A. Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men. Am J Cardiol 1996;77:1179-84.
33. Armitage P, Berry G. Statistical methods in medical research, 2nd ed. Oxford, UK: Blackwell Scientific Publications, 1987:90.
34. Berlin JA, Laird NM, Sacks HS, Chalmers TC. A comparison of statistical methods for combining event rates from clinical trials. Stat Med 1989;8:141-51.
35. Craig WY, Poulin SE, Forster NR, Neveux LM, Wald NJ, Ledue TB. Effect of sample storage on the assay of lipoprotein(a) by commercially available radial immunodiffusion and enzyme-linked immunosorbent assay kits. Clin Chem 1992;38:550-3.
36. Utermann G, Menzel HJ, Kraft HG, Duba HC, Kemmler HG, Seitz C. Lp(a) glycoprotein phenotypes. J Clin Investig 1987;80:458-65.
37. Maher VMG, Brown BG, Marcovina SM, Hillger LA, Zhao X-Q, Albers JJ. Effects of lowering elevated LDL cholesterol on the cardiovascular risk of lipoprotein(a). JAMA 1995;274:1771-4.
38. Rader DJ, Hoeg JM, Brewer HB Jr. Quantitation of plasma apolipoproteins in the primary and secondary prevention of coronary artery disease. Ann Intern Med 1994;120:1012-5.
39. Angelin B. Therapy for lowering lipoprotein(a) levels. Curr Opin Lipidol 1997;8:337-41.